SEGMENT REPORTING (Tables)

9 Months Ended

Sep. 30, 2018

Summarized financial information concerning the Company's reportable segments is shown in the following tables (in thousands):



Three Months Ended September 30, 2018	Core Companion Animal Health			Other Vaccines, Pharmaceuticals and Products		Total
Total revenue	$	27,190		$	3,765	$	30,955
Operating (loss) income	(4,402		)	807		(3,595		)
(Loss) income before income taxes	(4,352		)	807		(3,545		)
Capital expenditures	20			229		249
Depreciation and amortization	823			317		1,140



Three Months Ended September 30, 2017	Core Companion Animal Health		Other Vaccines, Pharmaceuticals and Products		Total
Total revenue	$	25,578	$	4,758	$	30,336
Operating income	3,068		710		3,778
Income before income taxes	3,074		710		3,784
Capital expenditures	34		669		703
Depreciation and amortization	935		259		1,194



Nine Months Ended September 30, 2018	Core Companion Animal Health		Other Vaccines, Pharmaceuticals and Products		Total
Total revenue	$	80,652	$	12,729	$	93,381
Operating Income	384		95		479
Income before income taxes	347		95		442
Capital expenditures	117		944		1,061
Depreciation and amortization	2,568		905		3,473



Nine Months Ended September 30, 2017	Core Companion Animal Health		Other Vaccines, Pharmaceuticals and Products		Total
Total revenue	$	75,453	$	17,847	$	93,300
Operating income	6,763		4,363		11,126
Income before income taxes	6,971		4,341		11,312
Capital expenditures	119		1,879		1,998
Depreciation and amortization	2,837		749		3,586

Asset information by reportable segment as of September 30, 2018 is as follows (in thousands):



	Core Companion Animal Health		Other Vaccines, Pharmaceuticals and Products		Total
Total assets	$	123,326	$	20,794	$	144,120
Net assets	87,050		24,551		111,601

Asset information by reportable segment as of December 31, 2017 is as follows (in thousands):



	Core Companion Animal Health		Other Vaccines, Pharmaceuticals and Products		Total
Total assets	$	111,968	$	23,819	$	135,787
Net assets	75,984		24,456		100,440